AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 145 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $296,820 | +96.2% | 19,618 | -2.8% | 0.00% | – |
| Q2 2022 | $151,320 | -12.3% | 20,176 | +6.5% | 0.00% | – |
| Q1 2022 | $172,445 | +2.0% | 18,950 | -21.3% | 0.00% | – |
| Q4 2021 | $169,000 | -37.6% | 24,089 | +1.2% | 0.00% | – |
| Q3 2021 | $271,000 | -32.2% | 23,792 | -4.8% | 0.00% | – |
| Q2 2021 | $400,000 | +2.8% | 24,995 | +14.9% | 0.00% | – |
| Q1 2021 | $389,000 | +23.1% | 21,760 | -6.8% | 0.00% | – |
| Q4 2020 | $316,000 | +19.7% | 23,354 | +4.0% | 0.00% | – |
| Q3 2020 | $264,000 | -21.2% | 22,457 | 0.0% | 0.00% | – |
| Q2 2020 | $335,000 | -9.2% | 22,457 | -17.8% | 0.00% | – |
| Q1 2020 | $369,000 | -40.1% | 27,330 | +7.2% | 0.00% | -100.0% |
| Q4 2019 | $616,000 | +14.9% | 25,498 | -3.3% | 0.00% | 0.0% |
| Q3 2019 | $536,000 | -31.3% | 26,364 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $780,000 | -29.7% | 26,393 | +12.9% | 0.00% | 0.0% |
| Q1 2019 | $1,110,000 | +42.1% | 23,379 | +8.2% | 0.00% | 0.0% |
| Q4 2018 | $781,000 | -45.2% | 21,610 | -6.7% | 0.00% | -50.0% |
| Q3 2018 | $1,425,000 | -20.2% | 23,158 | -12.4% | 0.00% | 0.0% |
| Q2 2018 | $1,786,000 | +29.6% | 26,434 | +4.0% | 0.00% | 0.0% |
| Q1 2018 | $1,378,000 | -8.7% | 25,409 | +0.5% | 0.00% | 0.0% |
| Q4 2017 | $1,510,000 | +24.7% | 25,279 | +1.5% | 0.00% | +100.0% |
| Q3 2017 | $1,211,000 | -1.9% | 24,898 | +5.9% | 0.00% | -50.0% |
| Q2 2017 | $1,235,000 | +22.3% | 23,501 | +5.5% | 0.00% | +100.0% |
| Q1 2017 | $1,010,000 | +41.5% | 22,266 | +18.1% | 0.00% | 0.0% |
| Q4 2016 | $714,000 | +12.1% | 18,856 | +11.7% | 0.00% | 0.0% |
| Q3 2016 | $637,000 | +112.3% | 16,886 | -0.9% | 0.00% | – |
| Q2 2016 | $300,000 | +75.4% | 17,038 | +20.6% | 0.00% | – |
| Q1 2016 | $171,000 | -47.7% | 14,131 | +5.2% | 0.00% | – |
| Q4 2015 | $327,000 | +38.6% | 13,433 | +1.2% | 0.00% | – |
| Q3 2015 | $236,000 | +0.9% | 13,276 | 0.0% | 0.00% | – |
| Q2 2015 | $234,000 | +1.3% | 13,276 | +79.7% | 0.00% | – |
| Q1 2015 | $231,000 | +10.0% | 7,388 | +2.4% | 0.00% | – |
| Q4 2014 | $210,000 | +38.2% | 7,212 | -1.8% | 0.00% | – |
| Q3 2014 | $152,000 | -19.1% | 7,345 | -2.9% | 0.00% | – |
| Q2 2014 | $188,000 | +35.3% | 7,562 | +15.6% | 0.00% | – |
| Q1 2014 | $139,000 | – | 6,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|